Gradual tapering TNF inhibitors versus conventional synthetic DMARDs after achieving controlled disease in patients with rheumatoid arthritis: first-year results of the randomised controlled TARA study

Dosing down with biologic therapies: a systematic review and clinicians’ perspective

(2017) Christopher J Edwards et al.   RHEUMATOLOGY

Imaging Progression despite Clinical Remission in Early Rheumatoid Arthritis Patients after Etanercept Interruption

(2017) B. Laganà et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

(2016) T M Kuijper et al.   ANNALS OF THE RHEUMATIC DISEASES

Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions

(2016) Georg Schett et al.   ANNALS OF THE RHEUMATIC DISEASES

Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial

(2016) Marjan Ghiti Moghadam et al.   Arthritis & Rheumatology

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

(2015) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study

(2015) Judith Haschka et al.   ANNALS OF THE RHEUMATIC DISEASES

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial(STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)

(2015) Bruno Fautrel et al.   ANNALS OF THE RHEUMATIC DISEASES

De-intensifying treatment in established rheumatoid arthritis (RA): Why, how, when and in whom can DMARDs be tapered?

(2015) Bruno Fautrel et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review

(2015) T. M. Kuijper et al.   JOURNAL OF RHEUMATOLOGY

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

(2015) N. van Herwaarden et al.   BMJ-British Medical Journal

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

(2015) N. van Herwaarden et al.   BMJ-British Medical Journal

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

(2015) Jasvinder A. Singh et al.   Arthritis & Rheumatology

Chronological reading of radiographs in rheumatoid arthritis increases efficiency and does not lead to bias

(2013) Lilian H D van Tuyl et al.   ANNALS OF THE RHEUMATIC DISEASES

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

(2013) Josef S Smolen et al.   LANCET

Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

(2010) M. Schoels et al.   ANNALS OF THE RHEUMATIC DISEASES

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study

(2010) N. B. Klarenbeek et al.   ANNALS OF THE RHEUMATIC DISEASES

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

(2010) Y. Tanaka et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study

(2009) Benazir Saleem et al.   ARTHRITIS AND RHEUMATISM